The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Calcimimetic Market Research Report 2025
Synopsis
A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT).
The global Calcimimetic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.
This report aims to provide a comprehensive presentation of the global market for Calcimimetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcimimetic.
Report Scope
The Calcimimetic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcimimetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcimimetic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd
Segment by Type
Cinacalcet
Etelcalcetide
Evocalcet
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Calcimimetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Calcimimetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT).
The global Calcimimetic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.
This report aims to provide a comprehensive presentation of the global market for Calcimimetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcimimetic.
Report Scope
The Calcimimetic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Calcimimetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calcimimetic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd
Segment by Type
Cinacalcet
Etelcalcetide
Evocalcet
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Calcimimetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Calcimimetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Calcimimetic Market Overview
1.1 Product Overview and Scope of Calcimimetic
1.2 Calcimimetic Segment by Type
1.2.1 Global Calcimimetic Market Value Comparison by Type (2024-2030)
1.2.2 Cinacalcet
1.2.3 Etelcalcetide
1.2.4 Evocalcet
1.3 Calcimimetic Segment by Application
1.3.1 Global Calcimimetic Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Calcimimetic Market Size Estimates and Forecasts
1.4.1 Global Calcimimetic Revenue 2019-2030
1.4.2 Global Calcimimetic Sales 2019-2030
1.4.3 Global Calcimimetic Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Calcimimetic Market Competition by Manufacturers
2.1 Global Calcimimetic Sales Market Share by Manufacturers (2019-2024)
2.2 Global Calcimimetic Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Calcimimetic Average Price by Manufacturers (2019-2024)
2.4 Global Calcimimetic Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Calcimimetic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Calcimimetic, Product Type & Application
2.7 Calcimimetic Market Competitive Situation and Trends
2.7.1 Calcimimetic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Calcimimetic Players Market Share by Revenue
2.7.3 Global Calcimimetic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Calcimimetic Retrospective Market Scenario by Region
3.1 Global Calcimimetic Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Calcimimetic Global Calcimimetic Sales by Region: 2019-2030
3.2.1 Global Calcimimetic Sales by Region: 2019-2024
3.2.2 Global Calcimimetic Sales by Region: 2025-2030
3.3 Global Calcimimetic Global Calcimimetic Revenue by Region: 2019-2030
3.3.1 Global Calcimimetic Revenue by Region: 2019-2024
3.3.2 Global Calcimimetic Revenue by Region: 2025-2030
3.4 North America Calcimimetic Market Facts & Figures by Country
3.4.1 North America Calcimimetic Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Calcimimetic Sales by Country (2019-2030)
3.4.3 North America Calcimimetic Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Calcimimetic Market Facts & Figures by Country
3.5.1 Europe Calcimimetic Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Calcimimetic Sales by Country (2019-2030)
3.5.3 Europe Calcimimetic Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Calcimimetic Market Facts & Figures by Country
3.6.1 Asia Pacific Calcimimetic Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Calcimimetic Sales by Country (2019-2030)
3.6.3 Asia Pacific Calcimimetic Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Calcimimetic Market Facts & Figures by Country
3.7.1 Latin America Calcimimetic Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Calcimimetic Sales by Country (2019-2030)
3.7.3 Latin America Calcimimetic Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Calcimimetic Market Facts & Figures by Country
3.8.1 Middle East and Africa Calcimimetic Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Calcimimetic Sales by Country (2019-2030)
3.8.3 Middle East and Africa Calcimimetic Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Calcimimetic Sales by Type (2019-2030)
4.1.1 Global Calcimimetic Sales by Type (2019-2024)
4.1.2 Global Calcimimetic Sales by Type (2025-2030)
4.1.3 Global Calcimimetic Sales Market Share by Type (2019-2030)
4.2 Global Calcimimetic Revenue by Type (2019-2030)
4.2.1 Global Calcimimetic Revenue by Type (2019-2024)
4.2.2 Global Calcimimetic Revenue by Type (2025-2030)
4.2.3 Global Calcimimetic Revenue Market Share by Type (2019-2030)
4.3 Global Calcimimetic Price by Type (2019-2030)
5 Segment by Application
5.1 Global Calcimimetic Sales by Application (2019-2030)
5.1.1 Global Calcimimetic Sales by Application (2019-2024)
5.1.2 Global Calcimimetic Sales by Application (2025-2030)
5.1.3 Global Calcimimetic Sales Market Share by Application (2019-2030)
5.2 Global Calcimimetic Revenue by Application (2019-2030)
5.2.1 Global Calcimimetic Revenue by Application (2019-2024)
5.2.2 Global Calcimimetic Revenue by Application (2025-2030)
5.2.3 Global Calcimimetic Revenue Market Share by Application (2019-2030)
5.3 Global Calcimimetic Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Calcimimetic Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Ono Pharmaceutical
6.2.1 Ono Pharmaceutical Corporation Information
6.2.2 Ono Pharmaceutical Description and Business Overview
6.2.3 Ono Pharmaceutical Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ono Pharmaceutical Calcimimetic Product Portfolio
6.2.5 Ono Pharmaceutical Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurobindo Pharma Calcimimetic Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Roche Holding AG
6.4.1 Roche Holding AG Corporation Information
6.4.2 Roche Holding AG Description and Business Overview
6.4.3 Roche Holding AG Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Holding AG Calcimimetic Product Portfolio
6.4.5 Roche Holding AG Recent Developments/Updates
6.5 Lilly
6.5.1 Lilly Corporation Information
6.5.2 Lilly Description and Business Overview
6.5.3 Lilly Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lilly Calcimimetic Product Portfolio
6.5.5 Lilly Recent Developments/Updates
6.6 Merck & Co., Inc.
6.6.1 Merck & Co., Inc. Corporation Information
6.6.2 Merck & Co., Inc. Description and Business Overview
6.6.3 Merck & Co., Inc. Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck & Co., Inc. Calcimimetic Product Portfolio
6.6.5 Merck & Co., Inc. Recent Developments/Updates
6.7 Johnsons & Johnsons
6.6.1 Johnsons & Johnsons Corporation Information
6.6.2 Johnsons & Johnsons Description and Business Overview
6.6.3 Johnsons & Johnsons Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnsons & Johnsons Calcimimetic Product Portfolio
6.7.5 Johnsons & Johnsons Recent Developments/Updates
6.8 Bristol Myers Squibb
6.8.1 Bristol Myers Squibb Corporation Information
6.8.2 Bristol Myers Squibb Description and Business Overview
6.8.3 Bristol Myers Squibb Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol Myers Squibb Calcimimetic Product Portfolio
6.8.5 Bristol Myers Squibb Recent Developments/Updates
6.9 Accord Healthcare , Inc.
6.9.1 Accord Healthcare , Inc. Corporation Information
6.9.2 Accord Healthcare , Inc. Description and Business Overview
6.9.3 Accord Healthcare , Inc. Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Accord Healthcare , Inc. Calcimimetic Product Portfolio
6.9.5 Accord Healthcare , Inc. Recent Developments/Updates
6.10 Alkem Labs
6.10.1 Alkem Labs Corporation Information
6.10.2 Alkem Labs Description and Business Overview
6.10.3 Alkem Labs Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Alkem Labs Calcimimetic Product Portfolio
6.10.5 Alkem Labs Recent Developments/Updates
6.11 Viatris
6.11.1 Viatris Corporation Information
6.11.2 Viatris Calcimimetic Description and Business Overview
6.11.3 Viatris Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Viatris Calcimimetic Product Portfolio
6.11.5 Viatris Recent Developments/Updates
6.12 Teva Pharmaceutical Industries Ltd
6.12.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.12.2 Teva Pharmaceutical Industries Ltd Calcimimetic Description and Business Overview
6.12.3 Teva Pharmaceutical Industries Ltd Calcimimetic Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Teva Pharmaceutical Industries Ltd Calcimimetic Product Portfolio
6.12.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Calcimimetic Industry Chain Analysis
7.2 Calcimimetic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Calcimimetic Production Mode & Process
7.4 Calcimimetic Sales and Marketing
7.4.1 Calcimimetic Sales Channels
7.4.2 Calcimimetic Distributors
7.5 Calcimimetic Customers
8 Calcimimetic Market Dynamics
8.1 Calcimimetic Industry Trends
8.2 Calcimimetic Market Drivers
8.3 Calcimimetic Market Challenges
8.4 Calcimimetic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Calcimimetic Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Calcimimetic Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Calcimimetic Market Competitive Situation by Manufacturers in 2023
Table 4. Global Calcimimetic Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Calcimimetic Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Calcimimetic Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Calcimimetic Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Calcimimetic Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Calcimimetic, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Calcimimetic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Calcimimetic, Product Type & Application
Table 12. Global Key Manufacturers of Calcimimetic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Calcimimetic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcimimetic as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Calcimimetic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Calcimimetic Sales by Region (2019-2024) & (K Units)
Table 18. Global Calcimimetic Sales Market Share by Region (2019-2024)
Table 19. Global Calcimimetic Sales by Region (2025-2030) & (K Units)
Table 20. Global Calcimimetic Sales Market Share by Region (2025-2030)
Table 21. Global Calcimimetic Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Calcimimetic Revenue Market Share by Region (2019-2024)
Table 23. Global Calcimimetic Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Calcimimetic Revenue Market Share by Region (2025-2030)
Table 25. North America Calcimimetic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Calcimimetic Sales by Country (2019-2024) & (K Units)
Table 27. North America Calcimimetic Sales by Country (2025-2030) & (K Units)
Table 28. North America Calcimimetic Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Calcimimetic Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Calcimimetic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Calcimimetic Sales by Country (2019-2024) & (K Units)
Table 32. Europe Calcimimetic Sales by Country (2025-2030) & (K Units)
Table 33. Europe Calcimimetic Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Calcimimetic Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Calcimimetic Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Calcimimetic Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Calcimimetic Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Calcimimetic Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Calcimimetic Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Calcimimetic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Calcimimetic Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Calcimimetic Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Calcimimetic Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Calcimimetic Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Calcimimetic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Calcimimetic Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Calcimimetic Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Calcimimetic Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Calcimimetic Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Calcimimetic Sales (K Units) by Type (2019-2024)
Table 51. Global Calcimimetic Sales (K Units) by Type (2025-2030)
Table 52. Global Calcimimetic Sales Market Share by Type (2019-2024)
Table 53. Global Calcimimetic Sales Market Share by Type (2025-2030)
Table 54. Global Calcimimetic Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Calcimimetic Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Calcimimetic Revenue Market Share by Type (2019-2024)
Table 57. Global Calcimimetic Revenue Market Share by Type (2025-2030)
Table 58. Global Calcimimetic Price (US$/Unit) by Type (2019-2024)
Table 59. Global Calcimimetic Price (US$/Unit) by Type (2025-2030)
Table 60. Global Calcimimetic Sales (K Units) by Application (2019-2024)
Table 61. Global Calcimimetic Sales (K Units) by Application (2025-2030)
Table 62. Global Calcimimetic Sales Market Share by Application (2019-2024)
Table 63. Global Calcimimetic Sales Market Share by Application (2025-2030)
Table 64. Global Calcimimetic Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Calcimimetic Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Calcimimetic Revenue Market Share by Application (2019-2024)
Table 67. Global Calcimimetic Revenue Market Share by Application (2025-2030)
Table 68. Global Calcimimetic Price (US$/Unit) by Application (2019-2024)
Table 69. Global Calcimimetic Price (US$/Unit) by Application (2025-2030)
Table 70. Amgen Corporation Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Amgen Calcimimetic Product
Table 74. Amgen Recent Developments/Updates
Table 75. Ono Pharmaceutical Corporation Information
Table 76. Ono Pharmaceutical Description and Business Overview
Table 77. Ono Pharmaceutical Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Ono Pharmaceutical Calcimimetic Product
Table 79. Ono Pharmaceutical Recent Developments/Updates
Table 80. Aurobindo Pharma Corporation Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Aurobindo Pharma Calcimimetic Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. Roche Holding AG Corporation Information
Table 86. Roche Holding AG Description and Business Overview
Table 87. Roche Holding AG Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Roche Holding AG Calcimimetic Product
Table 89. Roche Holding AG Recent Developments/Updates
Table 90. Lilly Corporation Information
Table 91. Lilly Description and Business Overview
Table 92. Lilly Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Lilly Calcimimetic Product
Table 94. Lilly Recent Developments/Updates
Table 95. Merck & Co., Inc. Corporation Information
Table 96. Merck & Co., Inc. Description and Business Overview
Table 97. Merck & Co., Inc. Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Merck & Co., Inc. Calcimimetic Product
Table 99. Merck & Co., Inc. Recent Developments/Updates
Table 100. Johnsons & Johnsons Corporation Information
Table 101. Johnsons & Johnsons Description and Business Overview
Table 102. Johnsons & Johnsons Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Johnsons & Johnsons Calcimimetic Product
Table 104. Johnsons & Johnsons Recent Developments/Updates
Table 105. Bristol Myers Squibb Corporation Information
Table 106. Bristol Myers Squibb Description and Business Overview
Table 107. Bristol Myers Squibb Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Bristol Myers Squibb Calcimimetic Product
Table 109. Bristol Myers Squibb Recent Developments/Updates
Table 110. Accord Healthcare , Inc. Corporation Information
Table 111. Accord Healthcare , Inc. Description and Business Overview
Table 112. Accord Healthcare , Inc. Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Accord Healthcare , Inc. Calcimimetic Product
Table 114. Accord Healthcare , Inc. Recent Developments/Updates
Table 115. Alkem Labs Corporation Information
Table 116. Alkem Labs Description and Business Overview
Table 117. Alkem Labs Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Alkem Labs Calcimimetic Product
Table 119. Alkem Labs Recent Developments/Updates
Table 120. Viatris Corporation Information
Table 121. Viatris Description and Business Overview
Table 122. Viatris Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Viatris Calcimimetic Product
Table 124. Viatris Recent Developments/Updates
Table 125. Teva Pharmaceutical Industries Ltd Corporation Information
Table 126. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 127. Teva Pharmaceutical Industries Ltd Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Teva Pharmaceutical Industries Ltd Calcimimetic Product
Table 129. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Calcimimetic Distributors List
Table 133. Calcimimetic Customers List
Table 134. Calcimimetic Market Trends
Table 135. Calcimimetic Market Drivers
Table 136. Calcimimetic Market Challenges
Table 137. Calcimimetic Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Calcimimetic
Figure 2. Global Calcimimetic Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Calcimimetic Market Share by Type in 2023 & 2030
Figure 4. Cinacalcet Product Picture
Figure 5. Etelcalcetide Product Picture
Figure 6. Evocalcet Product Picture
Figure 7. Global Calcimimetic Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Calcimimetic Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Global Calcimimetic Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Calcimimetic Market Size (2019-2030) & (US$ Million)
Figure 13. Global Calcimimetic Sales (2019-2030) & (K Units)
Figure 14. Global Calcimimetic Average Price (US$/Unit) & (2019-2030)
Figure 15. Calcimimetic Report Years Considered
Figure 16. Calcimimetic Sales Share by Manufacturers in 2023
Figure 17. Global Calcimimetic Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Calcimimetic Players: Market Share by Revenue in 2023
Figure 19. Calcimimetic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Calcimimetic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Calcimimetic Sales Market Share by Country (2019-2030)
Figure 22. North America Calcimimetic Revenue Market Share by Country (2019-2030)
Figure 23. United States Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Calcimimetic Sales Market Share by Country (2019-2030)
Figure 26. Europe Calcimimetic Revenue Market Share by Country (2019-2030)
Figure 27. Germany Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Calcimimetic Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Calcimimetic Revenue Market Share by Region (2019-2030)
Figure 34. China Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Calcimimetic Sales Market Share by Country (2019-2030)
Figure 44. Latin America Calcimimetic Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Calcimimetic Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Calcimimetic Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Calcimimetic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Calcimimetic by Type (2019-2030)
Figure 54. Global Revenue Market Share of Calcimimetic by Type (2019-2030)
Figure 55. Global Calcimimetic Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Calcimimetic by Application (2019-2030)
Figure 57. Global Revenue Market Share of Calcimimetic by Application (2019-2030)
Figure 58. Global Calcimimetic Price (US$/Unit) by Application (2019-2030)
Figure 59. Calcimimetic Value Chain
Figure 60. Calcimimetic Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
